Prognostic factors for multiple sclerosis: the importance of natural history studies
- PMID: 16170495
- DOI: 10.1007/s00415-005-2012-4
Prognostic factors for multiple sclerosis: the importance of natural history studies
Abstract
Detailed studies of the natural history of untreated multiple sclerosis (MS) have been carried out in London, Ontario, Canada, over the past generation. There are now some 25,000 patient-years of follow-up in a cohort of slightly more than 1,000 individuals. From the data, it is clear that a number of factors are associated with long-term outcome of the disease. The Ontario database reveals several prognostic variables that are clinical in nature, which can be used to evaluate prognosis in any clinical subtype. The most important factors include the development of a progressive deficit and time to onset of progressive deficit. In addition, and independently, a high number of relapses in the first and second year is associated with poor long-term outcome, as is the development of early unremitting disability. An important question is whether or not primary-progressive (PP) MS represents an independent entity separate from secondary-progressive (SP) MS. No specific category of PP disease is distinguishable from SP disease using available clinical measures. There is reason to believe that magnetic resonance imaging (MRI) activity (when appropriately controlled for other unequally distributed factors, such as age) will be found to be very similar.
Similar articles
-
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625. Brain. 1999. PMID: 10219776
-
Natural history of multiple sclerosis: a unifying concept.Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16. Brain. 2006. PMID: 16415308
-
Early relapses, onset of progression, and late outcome in multiple sclerosis.JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599. JAMA Neurol. 2013. PMID: 23407713
-
Clinical prognostic factors in multiple sclerosis: a natural history review.Nat Rev Neurol. 2009 Dec;5(12):672-82. doi: 10.1038/nrneurol.2009.178. Nat Rev Neurol. 2009. PMID: 19953117 Review.
-
Natural history of multiple sclerosis: risk factors and prognostic indicators.Curr Opin Neurol. 2007 Jun;20(3):269-74. doi: 10.1097/WCO.0b013e32812583ad. Curr Opin Neurol. 2007. PMID: 17495619 Review.
Cited by
-
Aggressive multiple sclerosis: proposed definition and treatment algorithm.Nat Rev Neurol. 2015 Jul;11(7):379-89. doi: 10.1038/nrneurol.2015.85. Epub 2015 Jun 2. Nat Rev Neurol. 2015. PMID: 26032396 Review.
-
Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis.Ann Clin Transl Neurol. 2018 Sep 23;5(11):1362-1371. doi: 10.1002/acn3.646. eCollection 2018 Nov. Ann Clin Transl Neurol. 2018. PMID: 30480030 Free PMC article.
-
The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases.Front Mol Neurosci. 2025 Jan 10;17:1493308. doi: 10.3389/fnmol.2024.1493308. eCollection 2024. Front Mol Neurosci. 2025. PMID: 39866909 Free PMC article. Review.
-
Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis.Front Immunol. 2019 Mar 19;10:516. doi: 10.3389/fimmu.2019.00516. eCollection 2019. Front Immunol. 2019. PMID: 30941144 Free PMC article.
-
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):757-9. doi: 10.1136/jnnp.2006.107052. Epub 2007 Jan 12. J Neurol Neurosurg Psychiatry. 2007. PMID: 17220286 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous